IM

Imranhasan Mushtakhasan Kazi

Active Director Director DIN 08931193
DIN 08931193 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Imranhasan Mushtakhasan Kazi

Data last updated:

Imranhasan Mushtakhasan Kazi is a Director at Ergomed Pharmaceutical Private Limited (since 2020). The company operates in Pharma.

DIN 08931193
Primary Designation Director
Industry Pharma
First Appointment 23 Oct 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20202020Active

Board colleagues of Imranhasan Mushtakhasan Kazi

NameDINCompanyDesignation
Azharuddin Syed08931122Ergomed Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ergomed Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Imranhasan Mushtakhasan Kazi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Imranhasan Mushtakhasan Kazi

Imranhasan Mushtakhasan Kazi currently holds 1 directorship: Ergomed Pharmaceutical Private Limited (Director, since 23 Oct 2020).

Imranhasan Mushtakhasan Kazi was first appointed on 23 Oct 2020 as Director at Ergomed Pharmaceutical Private Limited.

The current boards of Imranhasan Mushtakhasan Kazi's companies include Azharuddin Syed (Ergomed Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available